Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 3
2006 1
2007 1
2011 3
2012 2
2013 1
2014 1
2015 1
2016 3
2017 2
2018 1
2019 4
2020 7
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional support management in resectable gastric cancer.
Serra F, Pedrazzoli P, Brugnatelli S, Pagani A, Corallo S, Rosti G, Caccialanza R, Viganò J, Carminati O. Serra F, et al. Among authors: brugnatelli s. Drugs Context. 2022 Oct 24;11:2022-5-1. doi: 10.7573/dic.2022-5-1. eCollection 2022. Drugs Context. 2022. PMID: 36339293 Free PMC article. Review.
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study.
Rosati G, Corsi D, Avallone A, Brugnatelli S, Dell'Aquila E, Cinausero M, Aprile G, Cicero G, Carlomagno C, Colombo A, Rapisardi S, Pinto C, Reggiardo G, Bilancia D. Rosati G, et al. Among authors: brugnatelli s. J Geriatr Oncol. 2022 Apr;13(3):302-307. doi: 10.1016/j.jgo.2021.10.007. Epub 2021 Oct 26. J Geriatr Oncol. 2022. PMID: 34716122
Peripheral Blood Lymphocyte Percentage May Predict Chemotolerance and Survival in Patients with Advanced Pancreatic Cancer. Association between Adaptive Immunity and Nutritional State.
Aquilani R, Brugnatelli S, Maestri R, Boschi F, Filippi B, Perrone L, Barbieri A, Buonocore D, Dossena M, Verri M. Aquilani R, et al. Among authors: brugnatelli s. Curr Oncol. 2021 Aug 26;28(5):3280-3296. doi: 10.3390/curroncol28050285. Curr Oncol. 2021. PMID: 34449579 Free PMC article.
Cytokine-Induced Memory-Like NK Cells with High Reactivity against Acute Leukemia Blasts and Solid Tumor Cells Suitable for Adoptive Immunotherapy Approaches.
Tanzi M, Consonni M, Falco M, Ferulli F, Montini E, Pasi A, Cacciatore R, Brugnatelli S, Pedrazzoli P, Zecca M, Boghen S, Dellabona P, Casorati G, Montagna D. Tanzi M, et al. Among authors: brugnatelli s. Cancers (Basel). 2021 Mar 30;13(7):1577. doi: 10.3390/cancers13071577. Cancers (Basel). 2021. PMID: 33808051 Free PMC article.
In reply to: "A COVID-19 screening tool for oncology telephone triage".
Lasagna A, Monaco T, Imarisio I, Brugnatelli S. Lasagna A, et al. Among authors: brugnatelli s. Support Care Cancer. 2021 Feb;29(2):541-542. doi: 10.1007/s00520-020-05841-y. Epub 2020 Oct 23. Support Care Cancer. 2021. PMID: 33095355 Free PMC article. No abstract available.
Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial.
Monti M, Morgagni P, Nanni O, Framarini M, Saragoni L, Marrelli D, Roviello F, Petrioli R, Fumagalli Romario U, Rimassa L, Bozzarelli S, Donini A, Graziosi L, De Angelis V, De Manzoni G, Bencivenga M, Mengardo V, Parma E, Milandri C, Mura G, Signorini A, Baiocchi G, Molfino S, Sgroi G, Steccanella F, Rausei S, Proserpio I, Viganò J, Brugnatelli S, Rinnovati A, Santi S, Ercolani G, Foca F, Valmorri L, Amadori D, Frassineti GL. Monti M, et al. Among authors: brugnatelli s. Cancers (Basel). 2020 Sep 29;12(10):E2790. doi: 10.3390/cancers12102790. Cancers (Basel). 2020. PMID: 33003302 Free PMC article.
Providing nutritional care to cancer patients during the COVID-19 pandemic: an Italian perspective.
Lobascio F, Caccialanza R, Monaco T, Cereda E, Secondino S, Masi S, Crotti S, Rizzo G, Cappello S, Borioli V, Inglardi M, Grugnetti G, Muzzi A, Triarico A, Pedrazzoli P, Brugnatelli S. Lobascio F, et al. Among authors: brugnatelli s. Support Care Cancer. 2020 Sep;28(9):3987-3989. doi: 10.1007/s00520-020-05557-z. Epub 2020 Jun 3. Support Care Cancer. 2020. PMID: 32495030 Free PMC article.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
34 results